Abstract
Abstract Surgical treatment consists of the gold standard approach in patients diagnosed with nonmetastatic renal cell carcinoma (RCC). However, a great proportion of such patients will relapse postoperatively and metastatic disease will develop. In the present study, we present a review of the literature about available data regarding adjuvant treatment options in patients with RCC treated surgically.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
